News Releases
Read all the latest news from Bristol Myers Squibb the Netherlands here.
30/03/23
News Releases
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis >
Bristol Myers Squibb today announced that the European Commission has approved Sotyktu (deucravacitinib), a first-in-class, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy, representing a new way of treating this chronic immune-mediated disease.
01/09/22
News Releases
Bristol Myers Squibb celebrates highest point in first European cell therapy production facility construction at Leiden Bio Science Park >
The construction of the CAR T cell therapy production centre of Bristol Myers Squibb in the Leiden Bio Science Park (LBSP) is nearing completion. Today the highest point was reached which traditionally means a topping-off ceremony.
Older articles
30/05/22
#MSconnections on World MS Day >
Contact details for media
Didn't find the information you were looking for or do you have further questions? Please contact us directly. We will be happy to help you out!
Ronald Jager
Senior Manager Corporate Affairs
Phone number: +31 30 300 22 22
E-mail: info.nl@bms.com
For all other questions
If you are not a member of the press and have a non-media related question then find the right contact information here. This will enable us to help you faster!